Ethical Aspects of the Abuse of Pharmaceutical Enhancements by Healthy People in the Context of Improving Cognitive Functions
This article explores the ethical issues of healthy individuals using pharmaceutical cognitive enhancers like modafinil to boost focus and performance. It raises concerns about fairness, social pressure, personal authenticity, and health risks, arguing that such use may deepen inequality and normalize drug use for non-medical purposes. The authors call for public education, regulation, and further research to address the societal and ethical challenges posed by cognitive enhancement.
0
1
Tags
Sport(s) Neurology
Disability Studies
Sport(s) Psychology
Health Psychology
Psychology
Social Science
Empirical Science
Science
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Pharmaceuticals as Treatment Options for Traumatic Brain Injuries (TBIs)
Ethical Aspects of the Abuse of Pharmaceutical Enhancements by Healthy People in the Context of Improving Cognitive Functions
Research Involvement of Individuals with Intellectual Disabilities
Social/Scientific Value
Scientific Validity
Favorable Risk–Benefit Ratio
Independent Review Boards
Ethical Aspects of the Abuse of Pharmaceutical Enhancements by Healthy People in the Context of Improving Cognitive Functions
"The White Version of Cheating?" Ethical and Social Equity Concerns of Cognitive Enhancing Drug Users in Higher Education.
Stigma in Attention Deficit Hyperactivity Disorder
ADHD and Identity Formation: Adolescents' Experiences From the Healthcare System and Peer Relationships
Implementing Justice in Research: Beyond Equitable Selection
Ableism, Technoableism, and Future AI
Definition Drives Design: Disability Models and Mechanisms of Bias in AI Technologies
This Is What a Historicist and Relativist Feminist Philosophy of Disability Looks Like
Chapter 1 Section 1: A Naturalized Narrative